QRLBIO006

Globally, neurosurgeons face a significant problem in treating traumatic brain/spinal cord injury. The central nervous system (CNS), when disrupted by brain and spinal cord injuries, leads to paralysis, sensory loss, and cognitive impairments. In traumatic injuries, inflammation and other complications worsen the damage caused and often result in permanent impairment. Better treatment options are needed because current treatments, such as medication and surgery manage symptoms rather than restoring the damaged part.

In India, the spinal cord injury affects between 250,000 and 500,000 people annually, according to WHO data. Most these Injuries result from incidents such falls, and road accidents. In India, traffic accidents claim the lives of up to 120,000 people and critically injure another 1.2 million. As per literature, 1.5 million individuals in India are having spinal cord injuries (SCIs) leading to thousands of deaths. Given this scenario, there is an urgent need for developing alternative treatment for brain and spinal cord injuries in India. We are developing an autologous cell-based therapy for treating brain and spinal cord injuries without surgery.